Business Case Studies, Value Chain Analysis Case Study, Novartis,Globalisation of Pharmaceutical Research

print page
Tell A Friend
Bookmark
 

Case Categories

Value Chain Analysis Case Study

IBS CDC IBS CDC IBS CDC IBS CDC RSS Feed
Case Title:

Novartis: Globalisation of Pharmaceutical Research

Publication Year : 2005

Authors: Soumitra Das, Sumit Kumar Chaudhuri

Industry: Health Care

Region:Switzerland

Case Code: VCA0010

Teaching Note: Not Available

Structured Assignment: Not Available

Buy This Case Study
OR





Abstract:
Until 2000-2001, the global pharmaceutical industry used to consider Novartis as a 'sleepy European giant' till it released Glivec, a therapeutic drug that established itself as one of the most successful cancer therapies. By the turn of the 21st century, while major pharma players globally were facing a crisis of patent expiry on key drugs and poor research results, Novartis had 10 new drug launches slated between 2000-2003, three times that of any of its competitors. It had a Strategic Alliances division, which by 2004 had signed over 320 collaborations, out of which 90 collaborations were with biotech companies and 230 with academic centres in 19 countries. Due to its innovative research strategies, Novartis was adjudged by Fortune, as the fourth best pharmaceutical company in the world in 2004.

Pedagogical Objective:

  • To discuss how Novartis, under the leadership of professor Paul Herrling, the head of corporate research, is making efforts to sustain its growth by leveraging on its globalised research strategy

Keywords : Pharmaceutical research; Innovation Management Case Study; Novartis; Blockbuster drugs; Patent expiry on blockbuster drugs; Generic drugs; Collaborative research in global pharmaceutical industry; Strategic alliances of Novartis; Novartis product pipeline

Contents:

  • Novartis-A Tradition of Research
  • Global Research Strategies of Novartis
  • What Lies Ahead?

Recently Bought Case Studies

    Recently Bought Case Studies
advertisement

    Executive Interviews

  • David ConklinDavid Conklin

    David Conklin, is a professor at the Richard Ivey School of Business
    Speaks on Government and Business
  • Lord Meghnad DesaiLord Meghnad Desai

    Lord Meghnad Desai, is an Indian-born British economist and Labor politician
    Speaks on Government and Business
  • Vijay GovindarajanVijay Govindarajan

    Vijay Govindarajan, is widely regarded as one of the world’s leading experts on strategy and innovation
    Speaks on Reverse Innovation
  • View All Executive Interviews»






Contact us: IBS Case Development Centre (IBSCDC), IFHE Campus, Donthanapally, Sankarapally Road, Hyderabad-501 504, Andhra Pradesh, INDIA.
Mob: +91- 9640901313, Phone: +91 - 08417 - 236672, Fax : + 91 - 08417 - 236674
E-mail: casehelpdesk@ibsindia.org

©2003-2010 IBS Case Development Centre. All rights reserved. | Careers | Privacy Policy | Terms of Use | Disclosure | Site Map xml sitemap